PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Jun-2022 Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share Dermapharm Holding SE
01-Jun-2022 Almac Discovery nominates a first candidate molecule from its Protein Drug Conjugate (PDC) Platform to progress into pre-clinical development Almac Discovery
01-Jun-2022 Vetter Publishes First Sustainability Report B3C newswire
01-Jun-2022 ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates ProQR Therapeutics N.V.
01-Jun-2022 HUTCHMED Announces TAZVERIK® Approved to be Used in Hainan Pilot Zone in China HUTCHMED
01-Jun-2022 Asgard Therapeutics Granted U.S. Patent for Dendritic Cell Reprogramming Asgard Therapeutics AB
01-Jun-2022 Samanta Cimitan Appointed Chief Business Officer at Celonic B3C newswire
01-Jun-2022 New data show statistically greater improvements in clinical outcomes with subcutaneous infliximab, compared to intravenous infliximab, in patients with rheumatoid arthritis INCHEON
01-Jun-2022 Bone Therapeutics Provides First Quarter 2022 Business Update Bone Therapeutics
01-Jun-2022 FDA grants efanesoctocog alfa Breakthrough Therapy designation for hemophilia A Sanofi
01-Jun-2022 Abivax phase 2a study results of obefazimod (ABX464) in rheumatoid arthritis published in the journal “Annals of the Rheumatic Diseases” and selected for presentation at EULAR 2022 ABIVAX
01-Jun-2022 Relief Therapeutics Announces Results of Annual General Meeting of RELIEF THERAPEUTICS Holding SA Relief Therapeutics Holding SA
31-May-2022 Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter Vita 34 AG
31-May-2022 FDA Approves Label Extension for Evrysdi® for Infants with Spinal Muscular Atrophy Under 2 Months Old PTC Therapeutics
31-May-2022 First subject dosed in Lipigon’s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical’s LNAplus™ technology platform Secarna Pharmaceuticals GmbH & Co. KG
31-May-2022 FDA accepts Dupixent® (dupilumab) for priority review in adults with prurigo nodularis Sanofi
31-May-2022 ALTURiX Acquires UK Rights to Liothyronine ALTURiX
31-May-2022 Birmingham Biotech and Tanner Pharma Group enter distribution partnership for innovative nasal spray in Latin America Sciad Newswire
31-May-2022 Patient centricity in drug innovation and packaging design to take centre stage at Connect in Pharma in Geneva this September Sciad Newswire
31-May-2022 Betül Susamis Unaran leaves Zur Rose Group Zur Rose Group AG